Mammary Neoplasms, Experimental - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Mammary Neoplasms, Experimental	go back to main search page
Accession:	RDO:0006058	browse the term
Definition:	Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Synonyms:	exact_synonym:	Experimental Mammary Neoplasm
	primary_id:	MESH:D008325

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Mammary Neoplasms, Experimental
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A			IEP	5	8,660,092	8,748,570	RGD:2315553	RGD
G	Abcb1b	ATP-binding cassette, sub-family B (MDR/TAP), member 1B			IEP	5	8,798,147	8,866,314	RGD:2315553	RGD
G	Agtr1a	angiotensin II receptor, type 1a			ISS	13	30,428,225	30,474,736	RGD:2292665	RGD
G	Akt1	thymoma viral proto-oncogene 1			IAGP	12	113,892,032	113,912,487	RGD:2315600	RGD
G	Akt2	thymoma viral proto-oncogene 2			IAGP	7	28,376,579	28,424,472	RGD:2315600	RGD
G	Alox5ap	arachidonate 5-lipoxygenase activating protein			ISS	5	150,076,634	150,099,623	RGD:2313895	RGD
G	Anxa1	annexin A1			ISS	19	20,447,924	20,465,161	RGD:2306898	RGD
G	Apaf1	apoptotic peptidase activating factor 1			ISS	10	90,452,056	90,545,488	RGD:2325748	RGD
G	Areg	amphiregulin			IEP	5	91,568,641	91,577,458	RGD:2292663	RGD
G	Areg	amphiregulin			ISS	5	91,568,641	91,577,458	RGD:2292665	RGD
G	Bak1	BCL2-antagonist/killer 1			IPM	17	27,156,757	27,165,571	RGD:2315700	RGD
G	Bard1	BRCA1 associated RING domain 1			IPM	1	71,074,109	71,149,546	RGD:2293149	RGD
G	Brca1	breast cancer 1			ISS	11	101,350,078	101,413,269	RGD:2293155	RGD
G	Brca1	breast cancer 1			ISS	11	101,350,078	101,413,269	RGD:1599502	RGD
G	Brca1	breast cancer 1		Susceptibility	IAGP	11	101,350,078	101,413,269	RGD:2293149	RGD
G	Cad	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase		Disease_progression	ISS	5	31,357,184	31,380,852	RGD:2303540	RGD
G	Car9	carbonic anhydrase 9			ISS	4	43,519,898	43,526,597	RGD:2293194	RGD
G	Casp1	caspase 1			IPM	9	5,298,517	5,307,281	RGD:2315886	RGD
G	Casp9	caspase 9			ISS	4	141,349,527	141,371,890	RGD:2315933	RGD
G	Casp9	caspase 9			IED	4	141,349,527	141,371,890	RGD:2315928	RGD
G	Cav1	caveolin 1, caveolae protein		Onset	IAGP	6	17,256,370	17,291,324	RGD:2289106	RGD
G	Cav1	caveolin 1, caveolae protein			IEP	6	17,256,370	17,291,324	RGD:2289100	RGD
G	Ccna2	cyclin A2			IEP	3	36,463,787	36,470,918	RGD:2293347	RGD
G	Ccnb1	cyclin B1			IEP	13	101,548,694	101,556,441	RGD:2315939	RGD
G	Ccnd1	cyclin D1			ISS	7	152,115,836	152,125,830	RGD:2289336	RGD
G	Ccnd1	cyclin D1			IPM	7	152,115,836	152,125,830	RGD:2296037	RGD
G	Ccnd1	cyclin D1			ISS	7	152,115,836	152,125,830	RGD:2289337	RGD
G	Ccnd3	cyclin D3			IPM	17	47,642,000	47,736,638	RGD:2316015	RGD
G	Ccnd3	cyclin D3			ISS	17	47,642,000	47,736,638	RGD:2316020	RGD
G	Ccne1	cyclin E1			ISS	7	38,883,003	38,892,509	RGD:2289336	RGD
G	Ccne1	cyclin E1			ISS	7	38,883,003	38,892,509	RGD:2289337	RGD
G	Ccr3	chemokine (C-C motif) receptor 3			IEP	9	123,936,703	123,946,421	RGD:6893427	RGD
G	Cdc25a	cell division cycle 25A			ISS	9	109,778,083	109,796,394	RGD:2764000	RGD
G	Cdc25a	cell division cycle 25A			IPM	9	109,778,083	109,796,394	RGD:2754551	RGD
G	Cdc25a	cell division cycle 25A			IPM	9	109,778,083	109,796,394	RGD:2771824	RGD
G	Cdh13	cadherin 13		Severity	IAGP	8	120,807,655	121,847,348	RGD:2293540	RGD
G	Cdk2	cyclin-dependent kinase 2			IEP	10	128,134,995	128,142,107	RGD:2293558	RGD
G	Cdk4	cyclin-dependent kinase 4			ISS	10	126,500,659	126,504,339	RGD:2293581	RGD
G	Cdk4	cyclin-dependent kinase 4		Susceptibility	IAGP	10	126,500,659	126,504,339	RGD:2293577	RGD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B			ISS	6	134,870,419	134,875,543	RGD:2293626	RGD
G	Cdkn2a	cyclin-dependent kinase inhibitor 2A		Disease_progression	IAGP	4	88,920,377	88,940,523	RGD:2289674	RGD
G	Col18a1	collagen, type XVIII, alpha 1		Severity	ISS	10	76,514,924	76,629,275	RGD:70690	RGD
G	Csf1	colony stimulating factor 1 (macrophage)			ISS	3	107,543,966	107,563,387	RGD:2293710	RGD
G	Ctnnb1	catenin (cadherin associated protein), beta 1			IAGP	9	120,842,518	120,869,625	RGD:2289674	RGD
G	Ctnnb1	catenin (cadherin associated protein), beta 1			IEP	9	120,842,518	120,869,625	RGD:2289816	RGD
G	Egfr	epidermal growth factor receptor			ISS	11	16,652,206	16,813,910	RGD:2289979	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			ISS	11	98,273,798	98,299,030	RGD:2289979	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			ISS	11	98,273,798	98,299,030	RGD:2289920	RGD
G	Erbb3	v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			ISS	10	128,006,424	128,026,557	RGD:2289979	RGD
G	Erbb4	v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)			ISS	1	68,086,540	69,154,633	RGD:2289979	RGD
G	Esr1	estrogen receptor 1 (alpha)		Susceptibility	IAGP	10	5,342,780	5,734,495	RGD:2290019	RGD
G	Fas	Fas (TNF receptor superfamily member 6)			IPM	19	34,365,149	34,402,260	RGD:2290047	RGD
G	Fbxo10	F-box protein 10			ISS	4	45,047,120	45,097,476	RGD:1601189	RGD
G	Fgf10	fibroblast growth factor 10			ISS	13	119,503,506	119,581,380	RGD:2292665	RGD
G	Fgf7	fibroblast growth factor 7			IPM	2	125,860,394	125,916,921	RGD:2301094	RGD
G	Fgf8	fibroblast growth factor 8			IPM	19	45,811,288	45,817,374	RGD:2301098	RGD
G	Flt3	FMS-like tyrosine kinase 3			IPM	5	148,142,317	148,212,065	RGD:2302211	RGD
G	Frmpd1	FERM and PDZ domain containing 1			ISS	4	45,197,778	45,298,808	RGD:1601189	RGD
G	Gh	growth hormone			ISS	11	106,161,582	106,163,124	RGD:2315650	RGD
G	Gsn	gelsolin			ISS	2	35,137,960	35,163,412	RGD:1599869	RGD
G	H19	H19 fetal liver mRNA			ISS	7	149,761,437	149,764,051	RGD:1642758	RGD
G	Hras1	Harvey rat sarcoma virus oncogene 1			ISS	7	148,375,833	148,379,903	RGD:2314834	RGD
G	Il18bp	interleukin 18 binding protein			ISS	7	109,163,591	109,166,669	RGD:2313895	RGD
G	Ilk	integrin linked kinase			ISS	7	112,885,104	112,891,439	RGD:2301733	RGD
G	Kdr	kinase insert domain protein receptor			ISS	5	76,329,290	76,374,453	RGD:5684399	RGD
G	Kdr	kinase insert domain protein receptor			ISS	5	76,329,290	76,374,453	RGD:2291936	RGD
G	Kit	kit oncogene			ISS	5	75,971,012	76,052,747	RGD:2302172	RGD
G	Krt7	keratin 7			ISS	15	101,242,834	101,258,237	RGD:2317439	RGD
G	Lhcgr	luteinizing hormone/choriogonadotropin receptor			ISS	17	89,140,889	89,191,316	RGD:2302177	RGD
G	Lnpep	leucyl/cystinyl aminopeptidase			ISS	17	17,664,687	17,761,453	RGD:1582109	RGD
G	Mmp13	matrix metallopeptidase 13		Severity	IEP	9	7,272,514	7,283,333	RGD:2306081	RGD
G	Mmp15	matrix metallopeptidase 15			IEP	8	97,876,237	97,898,193	RGD:2314949	RGD
G	Mmp2	matrix metallopeptidase 2			ISS	8	95,351,227	95,377,319	RGD:2325823	RGD
G	Mmp9	matrix metallopeptidase 9			ISS	2	164,773,751	164,781,346	RGD:2325823	RGD
G	Notch4	notch 4			ISS	17	34,701,240	34,725,488	RGD:2299154	RGD
G	Phb	prohibitin			ISS	11	95,528,271	95,542,087	RGD:2292404	RGD
G	Plau	plasminogen activator, urokinase		Disease_progression	ISS	14	21,655,884	21,662,610	RGD:6484140	RGD
G	Pten	phosphatase and tensin homolog		Onset	IAGP	19	32,832,067	32,900,650	RGD:2292496	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	1	151,947,254	151,955,147	RGD:5135030	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	1	151,947,254	151,955,147	RGD:2300130	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			IPM	1	151,947,254	151,955,147	RGD:2300118	RGD
G	Ptk2	PTK2 protein tyrosine kinase 2			ISS	15	73,035,535	73,253,621	RGD:2292560	RGD
G	Ptk2	PTK2 protein tyrosine kinase 2		Disease_progression	IAGP	15	73,035,535	73,253,621	RGD:2292554	RGD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)			IEP	19	5,637,490	5,648,130	RGD:2298764	RGD
G	Rnpep	arginyl aminopeptidase (aminopeptidase B)			ISS	1	137,159,276	137,180,661	RGD:1582109	RGD
G	Rxra	retinoid X receptor alpha			ISS	2	27,532,721	27,618,839	RGD:1643109	RGD
G	Socs1	suppressor of cytokine signaling 1			IEP	16	10,783,901	10,785,629	RGD:2298899	RGD
G	Socs3	suppressor of cytokine signaling 3			IEP	11	117,827,393	117,830,680	RGD:2298899	RGD
G	Stat1	signal transducer and activator of transcription 1			IEP	1	52,176,282	52,218,707	RGD:2291895	RGD
G	Stat3	signal transducer and activator of transcription 3			IED	11	100,748,124	100,800,825	RGD:2291914	RGD
G	Stat5a	signal transducer and activator of transcription 5A			ISS	11	100,720,665	100,746,483	RGD:2291932	RGD
G	Stat5a	signal transducer and activator of transcription 5A		Susceptibility	IAGP	11	100,720,665	100,746,483	RGD:2298539	RGD
G	Stat5a	signal transducer and activator of transcription 5A			ISS	11	100,720,665	100,746,483	RGD:2291927	RGD
G	Stat6	signal transducer and activator of transcription 6			IED	10	127,080,042	127,098,043	RGD:2298563	RGD
G	Stc2	stanniocalcin 2			ISS	11	31,259,441	31,270,061	RGD:2313895	RGD
G	Tdg	thymine DNA glycosylase			IEP	10	82,092,583	82,113,239	RGD:2317355	RGD
G	Terc	telomerase RNA component			IEP	3	96,218,360	96,218,756	RGD:2291975	RGD
G	Thbs1	thrombospondin 1			ISS	2	117,937,658	117,952,869	RGD:1626167	RGD
G	Tnfrsf10b	tumor necrosis factor receptor superfamily, member 10b			IPM	14	70,167,279	70,184,218	RGD:2290495	RGD
G	Trp53	transformation related protein 53		Disease_progression	IAGP	11	69,393,861	69,405,375	RGD:2290539	RGD
G	Trp53	transformation related protein 53			ISS	11	69,393,861	69,405,375	RGD:2290577	RGD
G	Txnip	thioredoxin interacting protein		Severity	ISS	3	96,361,880	96,365,780	RGD:1642758	RGD
G	Tyms	thymidylate synthase			ISS	5	30,384,740	30,400,165	RGD:2315839	RGD
G	Ube2i	ubiquitin-conjugating enzyme E2I			ISS	17	25,397,456	25,411,255	RGD:2301345	RGD
G	Wnt1	wingless-related MMTV integration site 1			IED	15	98,620,288	98,624,261	RGD:2298848	RGD
G	Wnt1	wingless-related MMTV integration site 1			IED	15	98,620,288	98,624,261	RGD:2298863	RGD
G	Wnt2	wingless-related MMTV integration site 2			ISS	6	17,938,940	17,980,445	RGD:2298848	RGD
G	Wnt2	wingless-related MMTV integration site 2			ISS	6	17,938,940	17,980,445	RGD:2298863	RGD
G	Wnt3	wingless-related MMTV integration site 3			IED	11	103,635,489	103,679,335	RGD:2298848	RGD
G	Wnt3a	wingless-related MMTV integration site 3A			IED	11	59,061,538	59,104,253	RGD:2298848	RGD
G	Wnt3a	wingless-related MMTV integration site 3A			IED	11	59,061,538	59,104,253	RGD:2298863	RGD
G	Wnt5b	wingless-related MMTV integration site 5B			IED	6	119,382,549	119,494,365	RGD:2298863	RGD
G	Wnt5b	wingless-related MMTV integration site 5B		No_Association	IED	6	119,382,549	119,494,365	RGD:2298848	RGD
G	Wnt6	wingless-related MMTV integration site 6			IED	1	74,818,466	74,831,893	RGD:2298848	RGD
G	Wnt6	wingless-related MMTV integration site 6		No_Association	IED	1	74,818,466	74,831,893	RGD:2298863	RGD
G	Wnt7a	wingless-related MMTV integration site 7A			IED	6	91,313,977	91,361,363	RGD:2298848	RGD
G	Wnt7a	wingless-related MMTV integration site 7A			IED	6	91,313,977	91,361,363	RGD:2298863	RGD
G	Wnt7b	wingless-related MMTV integration site 7B		No_Association	IED	15	85,365,867	85,412,251	RGD:2298848	RGD
G	Wnt7b	wingless-related MMTV integration site 7B			IED	15	85,365,867	85,412,251	RGD:2298863	RGD

Term paths to the root

Path 1
Term	Annotations
Diseases	25889
Neoplasms	4705
Neoplasms, Experimental	175
Mammary Neoplasms, Experimental	119
Path 2
Term	Annotations
Diseases	25889
Neoplasms	4705
Neoplasms by Site	3431
Mammary Neoplasms, Animal	129
Mammary Neoplasms, Experimental	119